At 10 °C, SH3
WT is entirely in the native, fully-folded state; 3 SH3 Mut exists as a dynamic mixture between the major native species (~98%) and an excited, folding intermediate (~2%); [3] [4] and the folding intermediate mimetic SH3
WT Δ57 is entirely in the intermediate state. 5 The intermediate state has essentially the same fold as the native state with the exception that the C-terminal b5 strand (residues 55-58) is disordered and no longer part of a b-sheet. 5 In our previous relaxation-based work on the kinetics of the interaction of SH3 folding intermediate mimetics with apo GroEL, we also studied a very closely related construct to SH3
WT D57 comprising a four-residue C-terminal truncation of the triple mutant, SH3 Mut D56. 5 The latter was not employed in the current work as, free in solution, it comprises a rapidly interconverting mixture between the major monomeric intermediate (~92%) with essentially the same structure as SH3
WT D57, a dimeric form of the intermediate (~4%) and a fully unfolded state (~4%) 5 that could potentially complicate interpretation of the PRE data. Free SH3
WT D57 shows no 15 N relaxation dispersion while large dispersions are observed for SH3 Mut D56; quantitative kinetic analysis of the modulation of 15 N dispersions by GroEL, in conjunction with lifetime line broadening and dark state exchange saturation transfer data, led to the identification of two bound states: one immobilized by binding to the walls of the GroEL cavity; the other mobile, confined and enriched within the GroEL cavity. 5 The current PRE data on SH3 WT D57 are fully consistent with the kinetic analysis of the relaxation-based data on the SH3 Mut D56-GroEL interaction (see main text).
GroEL mutations. The GroEL
E315C DNA sequence with all natural cysteines mutated to alanines and a cysteine introduced at position 315 (C138A, C458A, C519A, E315C) was synthesized by Genscript. 6 We subsequently introduced a point mutation at position 315 (C315E) to obtain the Cys0 construct corresponding to the wild type sequence without any cysteines. 6 The following mutations were introduced into the GroEL Cys0 construct using the QuickChange site-directed mutagenesis kit from Quiagen: S43C, A138C, R231C, R268C and G545C.The latter construct also contained an accidental deletion at Gly539; however, as the disordered Cterminal tail extends from residue 528 to 548, this deletion has no structural impact.
Expression and purification of GroEL. The initial purification in which GroEL is separated from other unbound proteins was carried out as described previously with 2 mM dithiothreitol (DTT) or 1 mM tris(2-carboxyethyl)phosphine) (TCEP) added to all buffers. [6] [7] Briefly, the plasmids for all mutants were transformed into BL21 Star TM (DE3) E. coli cells (Invitrogen), and expressed in Luria-Bertini broth (LB) at 37 °C. Induction was carried out at an OD600 = 0.8 with 0.5 mM isopropyl β-D-1-thiogalactopyranoside (IPTG) and the cultures grown overnight at 20 °C. Cells were lysed and nucleic acids removed by streptomycin sulfate precipitation. The sample was centrifuged for 25 min at 50,000 x g and the supernatant applied to a self-packed 60 ml ion exchange column (Q Sepharose FF, GE Healthcare). GroEL was subjected to ammonium sulfate precipitation and then injected on to a HiPrep Sephacryl S-300 gel filtration column (GE Healthcare). The final clean-up procedure to remove proteins bound within the GroEL cavity was carried out either by acetone precipitation 7 S3 in the case of the S43C, A138C and G545C mutants, or using the recently described disassembly/reassembly protocol 6 in the case of R231C, R268C and E315C mutants. The more time-consuming disassembly/reassembly procedure was only used in those cases where the acetone precipitation procedure either failed or resulted in very low yields. Assembly into a tetradecamer was confirmed by blue native polyacrylamide gel electrophoresis (BN-PAGE), and purity was assessed by the absence of tryptophan fluorescence 8 , sodium dodecylsulfate gel electrophoresis (SDS-PAGE) and mass spectrometry.
For the purposes of the current study, the effect of the various mutations used for spin-labeling on the ability of GroEL to undergo the various conformational changes accompanying ATP hydrolysis and binding of GroES is irrelevant, as the aim of the current work is directed at probing protein substrate sampling of the cavity of GroEL in the apo state. However, many of the sites of mutations used here have been used previously for functional studies with fluorescent labels, including S43C, 9-10 R231C 11 and E315C. 9, 12 The A138C mutation simply reintroduces the native cysteine at position 128. The tail is intrinsically disordered and hence the G545C mutation is unlikely to have any significant effect on function, especially since GroEL with a 7-residue Cterminal deletion at position 541 is still functional. 13 Although there is no data in the literature on the R268C mutant, the pattern of PREs observed for the spin-labeled R231C and R268C variants are very similar (see Fig.  2 , main text). ) and diamagnetic (EDTA-Ca 2+ ) tags to surface engineered cysteines on GroEL was carried out prior to the final clean-up procedure (i.e. either before acetone precipitation, or before reassembly into the tetradecamer). Briefly, DTT and TCEP were removed by overnight dialysis into 50 mM Tris. In the case of the disassembly/reassembly protocol the buffer also included 3 M urea. The GroEL mutants were incubated at room temperature overnight with a 4-10 fold molar excess of the paramagnetic or diamagnetic label. The conjugation reaction was verified by mass spectrometry. The samples were further purified using the appropriate final clean-up protocol, stored at 4 °C, and used within 2 weeks after paramagnetic labeling. . In addition, all NMR samples contained 0.03% (wt/vol) NaN3 and 5% (vol/vol) D2O.
Site

Control of interaction between
All NMR experiments were carried out at 10 °C on a Bruker 800 MHz NMR spectrometer equipped with a z gradient triple resonance cryoprobe. Assignments were taken from our previous work.
3, 5 1 HN-R2 values were obtained using a 1 H-15 N correlation-based experiment with a two-time point measurements recorded in an interleaved manner as described previously. 15 The 1 HN-G2 values are given by the difference 1 HN-R2 transverse relaxation rates recorded for paramagnetic and diamagnetic samples and calculated as:
where Ta and Tb are the two time points, and Idia and Ipara are peak intensities (i.e. peak heights) for the diamagnetic (Ca . Control experiments demonstrating that the same intermolecular PREs for SH3 Mut are obtained using either GroEL R268C conjugated to EDTA-Ca 2+ (top) or wild type GroEL (bottom) as the diamagnetic reference sample. These data indicate that lifetime line broadening arising from interaction of SH3
Mut with diamagnetic GroEL is the same for wild type and R268C-EDTA-Ca 2+ tagged GroEL, and that there is therefore no preferential binding to the EDTA-Ca 2+ tag. These control experiments complement those reported in Fig.  S1 . Figure S4 . Predicted solvent PREs (arising from random collisions with the paramagnetic label) calculated on the basis of solvent accessibility of backbone amide protons using the program Xplor-NIH [17] [18] (as described by Iwahara et al. 19 ) for SH3 WT (PDB 3UA6, with Val1 and Val5 substituted by Ser and Glu, respectively, to obtain the same sequence as found in Gallus gallus), 20 
